5-Amino-1MQ is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown. 5-Amino-1MQ is not fda-approved. available as research chemical. not scheduled or controlled. As with any research compound, individual responses vary.
Is 5-Amino-1MQ Safe?
Safety is the most important consideration with any research compound. 5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor with a safety profile established through preclinical research.
Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
What Are the Known Side Effects of 5-Amino-1MQ?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
These effects are based on preclinical data and community reports at standard dosages of 150-500 mcg subcutaneous, 50-100 mg oral. Higher doses generally increase both the likelihood and severity of side effects.
Are 5-Amino-1MQ Side Effects Dose-Dependent?
Most reported 5-Amino-1MQ side effects are dose-dependent — meaning they're more likely at higher doses and less likely at the lower end of the 150-500 mcg subcutaneous, 50-100 mg oral range.
This is why starting at the minimum effective dose and titrating up is the standard approach. With a half-life of not established in humans, any adverse effects will typically resolve within a few half-life periods after discontinuation.
What About Long-Term 5-Amino-1MQ Use?
Long-term safety data for 5-Amino-1MQ is limited, as with most research peptides. Standard cycles run 4-12 weeks.
5-Amino-1MQ is not fda-approved. available as research chemical. not scheduled or controlled. Extended use beyond recommended cycles should be approached with caution.
Does 5-Amino-1MQ Interact With Other Compounds?
Pairs well with NAD+ precursors (NMN, NR) for synergistic metabolic enhancement, and with MOTS-C for comprehensive mitochondrial optimization.
When stacking peptides, be aware that combining multiple compounds increases the total side-effect surface area. Monitor closely when introducing any new compound.
How Can You Minimize 5-Amino-1MQ Side Effects?
Start at the lower end of the dosage range (150-500 mcg subcutaneous, 50-100 mg oral). Use proper reconstitution and injection technique to minimize injection site reactions. Store correctly (lyophilized at -20°C, reconstituted at 2-8°C) to maintain purity.
Source only from vendors with third-party COA testing — contaminated or mislabeled products are a significant source of unexpected adverse effects.
What Is the Bottom Line on 5-Amino-1MQ Safety?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown. Overall, 5-Amino-1MQ is considered a compound requiring careful monitoring at standard research doses.
Read our 5-Amino-1MQ dosage guide for protocols designed to minimize risk.
Complete Guide
5-Amino-1MQ : Benefits, Dosage, Side Effects & Research
Related Reading
- 5-Amino-1MQ Dosage Guide
- 5-Amino-1MQ Benefits
- 5-Amino-1MQ Stacking Guide
- 5-Amino-1MQ Cycle Guide
- 5-Amino-1MQ Research
- MOTS-C Complete Guide
Calculate Your 5-Amino-1MQ Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 5-Amino-1MQ.
Open Calculator →Research-Grade Sourcing
If you're going to research 5-Amino-1MQ, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway. It is researched for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
What is the recommended 5-Amino-1MQ dosage?
Common dosages: 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily via subcutaneous injection or oral. Cycle length: 4-12 weeks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of 5-Amino-1MQ?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
Is 5-Amino-1MQ safe?
5-Amino-1MQ has shown a preliminary safety profile in research. Not FDA-approved. Available as research chemical. Not scheduled or controlled. All research should follow appropriate safety protocols.